344 related articles for article (PubMed ID: 22305837)
1. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.
Prunier F; Bière L; Gilard M; Boschat J; Mouquet F; Bauchart JJ; Charbonnier B; Genée O; Guérin P; Warin-Fresse K; Durand E; Lafont A; Christiaens L; Abi-Khalil W; Delépine S; Benard T; Furber A
Am Heart J; 2012 Feb; 163(2):200-7.e1. PubMed ID: 22305837
[TBL] [Abstract][Full Text] [Related]
2. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.
Desmet W; Bogaert J; Dubois C; Sinnaeve P; Adriaenssens T; Pappas C; Ganame J; Dymarkowski S; Janssens S; Belmans A; Van de Werf F
Eur Heart J; 2011 Apr; 32(7):867-77. PubMed ID: 21196444
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
6. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
[TBL] [Abstract][Full Text] [Related]
7. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
[TBL] [Abstract][Full Text] [Related]
8. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
Nijveldt R; Beek AM; Hofman MB; Umans VA; Algra PR; Spreeuwenberg MD; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):765-70. PubMed ID: 17891613
[TBL] [Abstract][Full Text] [Related]
9. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Patel MR; Westerhout CM; Granger CB; Brener SJ; Fu Y; Siha H; Kim RJ; Armstrong PW
Am Heart J; 2013 Feb; 165(2):226-33. PubMed ID: 23351826
[TBL] [Abstract][Full Text] [Related]
10. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
[TBL] [Abstract][Full Text] [Related]
11. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
[TBL] [Abstract][Full Text] [Related]
12. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
[TBL] [Abstract][Full Text] [Related]
13. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
14. Effect of infarct severity on regional and global left ventricular remodeling in patients with successfully reperfused ST segment elevation myocardial infarction.
Symons R; Masci PG; Goetschalckx K; Doulaptsis K; Janssens S; Bogaert J
Radiology; 2015 Jan; 274(1):93-102. PubMed ID: 25207466
[TBL] [Abstract][Full Text] [Related]
15. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
O'Neill WW; Martin JL; Dixon SR; Bartorelli AL; Trabattoni D; Oemrawsingh PV; Atsma DE; Chang M; Marquardt W; Oh JK; Krucoff MW; Gibbons RJ; Spears JR;
J Am Coll Cardiol; 2007 Jul; 50(5):397-405. PubMed ID: 17662390
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging.
Ripa RS; Nilsson JC; Wang Y; Søndergaard L; Jørgensen E; Kastrup J
Am Heart J; 2007 Nov; 154(5):929-36. PubMed ID: 17967600
[TBL] [Abstract][Full Text] [Related]
17. Effect of macroscopic-positive thrombus retrieval during primary percutaneous coronary intervention with thrombus aspiration on myocardial infarct size and microvascular obstruction.
Chopard R; Plastaras P; Jehl J; Janin S; Descotes Genon V; Seronde MF; Davani S; Kastler B; Schiele F; Meneveau N
Am J Cardiol; 2013 Jan; 111(2):159-65. PubMed ID: 23102881
[TBL] [Abstract][Full Text] [Related]
18. Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.
Haeck JD; Kuijt WJ; Koch KT; Bilodeau L; Henriques JP; Rohling WJ; Baan J; Vis MM; Nijveldt R; van Geloven N; Groenink M; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
Heart; 2010 Feb; 96(3):190-5. PubMed ID: 19858136
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
20. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
